Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
07 Jan 2025 |
MR01 |
Registration of charge 076140030005, created on 6 January 2025
|
|
|
09 Dec 2024 |
MR04 |
Satisfaction of charge 076140030004 in full
|
|
|
17 Sep 2024 |
AP01 |
Appointment of Mr Ashley Cartwright as a director on 5 September 2024
|
|
|
17 Sep 2024 |
TM01 |
Termination of appointment of Sanne Marie Lokke Olsen as a director on 5 September 2024
|
|
|
10 May 2024 |
CS01 |
Confirmation statement made on 26 April 2024 with no updates
|
|
|
30 Nov 2023 |
TM01 |
Termination of appointment of Markus Karl Altermatt as a director on 3 November 2023
|
|
|
03 Nov 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
10 May 2023 |
CS01 |
Confirmation statement made on 26 April 2023 with no updates
|
|
|
10 May 2023 |
PSC08 |
Notification of a person with significant control statement
|
|
|
11 Apr 2023 |
AP01 |
Appointment of Miss Sanne Marie Lokke Olsen as a director on 1 April 2023
|
|
|
03 Apr 2023 |
TM01 |
Termination of appointment of Peter Stephen Trickett as a director on 1 April 2023
|
|
|
07 Sep 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
10 May 2022 |
CS01 |
Confirmation statement made on 26 April 2022 with no updates
|
|
|
24 Sep 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
11 May 2021 |
CS01 |
Confirmation statement made on 26 April 2021 with no updates
|
|
|
30 Dec 2020 |
MR01 |
Registration of charge 076140030004, created on 23 December 2020
|
|
|
29 Dec 2020 |
PSC07 |
Cessation of Epax Pharma Uk Holdings Unlimited as a person with significant control on 28 May 2019
|
|
|
14 Sep 2020 |
AA |
Full accounts made up to 31 December 2019
|
|
|
03 Sep 2020 |
MR04 |
Satisfaction of charge 076140030003 in full
|
|
|
19 May 2020 |
CS01 |
Confirmation statement made on 26 April 2020 with updates
|
|
|
23 Aug 2019 |
AD01 |
Registered office address changed from C/O Fladgate Llp 16 Great Queen Street London WC2B 5DG United Kingdom to Kd Pharma Uk Limited Seal Sands Middlesbrough TS2 1UB on 23 August 2019
|
|
|
13 Jun 2019 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Declare dividend 21/05/2019
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
13 Jun 2019 |
SH01 |
Statement of capital following an allotment of shares on 20 May 2019
|
|
|
13 Jun 2019 |
RESOLUTIONS |
Resolutions
-
RES14 ‐
Ca[italise £3255829 20/05/2019
-
RES13 ‐
20/05/2019
|
|
|
13 Jun 2019 |
SH01 |
Statement of capital following an allotment of shares on 17 May 2019
|
|